LMMYOTCServices-Educational ServicesFiscal year ends May 31

Exousia Bio, Inc.

Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Jun 16, 2026

$0.01−0.00 (-18.29%)

Close on Oct 19, 2026

Market cap: $175.47K
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Feb 28, 2026

Exousia Bio reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Exousia Bio's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Exousia Bio's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LMMY.

Revenue growth-100.0% · median -16.8%

Company	Revenue	Growth
RMGL	$30.00K	-0.3%
BRWC	$20.00K	-33.3%
SMIO	$16.14K	–
LMMY	$0	-100.0%
RPDL	$0	–
EDTK	–	–

Company

Exchange: OTC
Industry: Services-Educational Services
Fiscal year ends: May 31
Auditor: BOLADALE LAWAL & CO.
SEC CIK: 1939937

Advertisement
300 × 250